These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23645841)

  • 41. Breadth of anti-merozoite antibody responses is associated with the genetic diversity of asymptomatic Plasmodium falciparum infections and protection against clinical malaria.
    Rono J; Osier FH; Olsson D; Montgomery S; Mhoja L; Rooth I; Marsh K; Färnert A
    Clin Infect Dis; 2013 Nov; 57(10):1409-16. PubMed ID: 23983244
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Allelic diversity and antibody recognition of Plasmodium falciparum merozoite surface protein 1 during hypoendemic malaria transmission in the Brazilian amazon region.
    Da Silveira LA; Dorta ML; Kimura EA; Katzin AM; Kawamoto F; Tanabe K; Ferreira MU
    Infect Immun; 1999 Nov; 67(11):5906-16. PubMed ID: 10531247
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Individuals living in a malaria-endemic area of Cameroon do not have an acquired antibody response to Plasmodium falciparum histidine-rich protein 2.
    Taylor DW; Bobbili N; Khadka VS; Quakyi IA; Leke RG
    Malar J; 2017 Feb; 16(1):58. PubMed ID: 28148260
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of the role of naturally acquired antibody levels to Plasmodium falciparum merozoite surface protein-1 in protecting Papua New Guinean children from malaria morbidity.
    al-Yaman F; Genton B; Kramer KJ; Chang SP; Hui GS; Baisor M; Alpers MP
    Am J Trop Med Hyg; 1996 May; 54(5):443-8. PubMed ID: 8644896
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of the RTS,S malaria vaccine candidate on naturally acquired antibody responses to multiple asexual blood stage antigens.
    Campo JJ; Dobaño C; Sacarlal J; Guinovart C; Mayor A; Angov E; Dutta S; Chitnis C; Macete E; Aponte JJ; Alonso PL
    PLoS One; 2011; 6(10):e25779. PubMed ID: 22022448
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of transmission intensity and age on subclass antibody responses to Plasmodium falciparum pre-erythrocytic and blood-stage antigens.
    Noland GS; Jansen P; Vulule JM; Park GS; Ondigo BN; Kazura JW; Moormann AM; John CC
    Acta Trop; 2015 Feb; 142():47-56. PubMed ID: 25446174
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities.
    Helb DA; Tetteh KK; Felgner PL; Skinner J; Hubbard A; Arinaitwe E; Mayanja-Kizza H; Ssewanyana I; Kamya MR; Beeson JG; Tappero J; Smith DL; Crompton PD; Rosenthal PJ; Dorsey G; Drakeley CJ; Greenhouse B
    Proc Natl Acad Sci U S A; 2015 Aug; 112(32):E4438-47. PubMed ID: 26216993
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antibody responses to a novel Plasmodium falciparum merozoite surface protein vaccine correlate with protection against experimental malaria infection in Aotus monkeys.
    Cavanagh DR; Kocken CH; White JH; Cowan GJ; Samuel K; Dubbeld MA; Voorberg-van der Wel A; Thomas AW; McBride JS; Arnot DE
    PLoS One; 2014; 9(1):e83704. PubMed ID: 24421900
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of Fcgamma receptor IIa (cd32) gene polymorphism and anti-malarial IgG subclass antibodies to asexual blood-stage antigen of Plasmodium falciparum in an unstable malaria endemic area of Iran.
    Zakeri S; Mashhadi R; Mehrizi AA; Djadid ND
    Exp Parasitol; 2013 May; 134(1):115-21. PubMed ID: 23458236
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibody Profiles to
    Ondigo BN; Hamre KES; Frosch AEP; Ayodo G; White MT; John CC
    Am J Trop Med Hyg; 2020 Dec; 103(6):2189-2197. PubMed ID: 33124539
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya.
    Polley SD; Conway DJ; Cavanagh DR; McBride JS; Lowe BS; Williams TN; Mwangi TW; Marsh K
    Vaccine; 2006 May; 24(19):4233-46. PubMed ID: 16111789
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Geographical patterns of allelic diversity in the Plasmodium falciparum malaria-vaccine candidate, merozoite surface protein-2.
    Hoffmann EH; da Silveira LA; Tonhosolo R; Pereira FJ; Ribeiro WL; Tonon AP; Kawamoto F; Ferreira MU
    Ann Trop Med Parasitol; 2001 Mar; 95(2):117-32. PubMed ID: 11299119
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationship between malaria incidence and IgG levels to Plasmodium falciparum merozoite antigens in Malian children: impact of hemoglobins S and C.
    Miura K; Diakite M; Diouf A; Doumbia S; Konate D; Keita AS; Moretz SE; Tullo G; Zhou H; Lopera-Mesa TM; Anderson JM; Fairhurst RM; Long CA
    PLoS One; 2013; 8(3):e60182. PubMed ID: 23555917
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of treating Schistosoma haematobium infection on Plasmodium falciparum-specific antibody responses.
    Reilly L; Magkrioti C; Mduluza T; Cavanagh DR; Mutapi F
    BMC Infect Dis; 2008 Nov; 8():158. PubMed ID: 19014683
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibody responses to repetitive epitopes of the circumsporozoite protein, liver stage antigen-1, and merozoite surface protein-2 in infants residing in a Plasmodium falciparum-hyperendemic area of western Kenya. XIII. Asembo Bay Cohort Project.
    Zhou Z; Xiao L; Branch OH; Kariuki S; Nahlen BL; Lal AA
    Am J Trop Med Hyg; 2002 Jan; 66(1):7-12. PubMed ID: 12135271
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Merozoite surface protein 2 allelic variation influences the specific antibody response during acute malaria in individuals from a Brazilian endemic area.
    Sallenave-Sales S; Faria CP; Zalis MG; Daniel-Ribeiro CT; Ferreira-da-Cruz Mde F
    Mem Inst Oswaldo Cruz; 2007 Jun; 102(3):421-4. PubMed ID: 17568950
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Variations in the quality of malaria-specific antibodies with transmission intensity in a seasonal malaria transmission area of Northern Ghana.
    Kusi KA; Manu EA; Manful Gwira T; Kyei-Baafour E; Dickson EK; Amponsah JA; Remarque EJ; Faber BW; Kocken CHM; Dodoo D; Gyan BA; Awandare GA; Atuguba F; Oduro AR; Koram KA
    PLoS One; 2017; 12(9):e0185303. PubMed ID: 28945794
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Natural antibody response to Plasmodium falciparum merozoite antigens MSP5, MSP9 and EBA175 is associated to clinical protection in the Brazilian Amazon.
    Medeiros MM; Fotoran WL; dalla Martha RC; Katsuragawa TH; Pereira da Silva LH; Wunderlich G
    BMC Infect Dis; 2013 Dec; 13():608. PubMed ID: 24373342
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Humoral responses to Plasmodium falciparum blood-stage antigens and association with incidence of clinical malaria in children living in an area of seasonal malaria transmission in Burkina Faso, West Africa.
    Nebie I; Diarra A; Ouedraogo A; Soulama I; Bougouma EC; Tiono AB; Konate AT; Chilengi R; Theisen M; Dodoo D; Remarque E; Bosomprah S; Milligan P; Sirima SB
    Infect Immun; 2008 Feb; 76(2):759-66. PubMed ID: 18070896
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Seasonal changes in the antibody responses against Plasmodium falciparum merozoite surface antigens in areas of differing malaria endemicity in Indonesia.
    Supargiyono S; Bretscher MT; Wijayanti MA; Sutanto I; Nugraheni D; Rozqie R; Kosasih AA; Sulistyawati S; Hawley WA; Lobo NF; Cook J; Drakeley CJ
    Malar J; 2013 Dec; 12():444. PubMed ID: 24321092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.